TLB-33
AssetAlso MT-2990
Binds and neutralizes IL-33 to potentially preserve thymic function and enhance immune resilience.
- Stage
- Human trials
- Modality
- Antibody
- Target
- IL33
- 1
- Indication
- 0
- Trials
- 1
- Developer
Indications
1Thymic preservation
Human trials, tolerancebio.com, 10 Oct 2026
In the full profile
- Targets and what it contains1
- Owner and partners1
- Evidence for its targets1
- Competitors1
Every asset’s record: target, stage, trials and the evidence behind it.